The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of patients with hormone receptor–positive breast cancer who need adjuvant tamoxifen therapy for more than 5 years.
Chiao-En Wu
No relevant relationships to disclose
Shin-Cheh Chen
No relevant relationships to disclose
Hsien-Kun Chang
No relevant relationships to disclose
Yung-Feng Lo
No relevant relationships to disclose
Swei Hsueh
No relevant relationships to disclose
Yung-Chang Lin
No relevant relationships to disclose